CTV News Channel with Dr. Sharon Cohen on FDA approval of Aducanumab
Dr. Sharon Cohen, Medical Director and Principal Investigator at Toronto Memory Program discusses the exciting news that FDA has approved the use of Aducanumab. The first new treatment for Alzheimer's disease in 20 years and the very first disease-modifying drug proven to slow AD progression.